FindTrial
Sign In

The role of lymph node dissection in neoadjuvant esophageal cancer patients: a single-center, retrospective clinical study

The role of lymph node dissection in neoadjuvant esophageal cancer patients: a single-center, retrospective clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118804
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-02-28
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

traditional lymph node dissection:None
selective lymph node dissection:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with locally advanced esophageal cancer who underwent surgery after neoadjuvant therapy at Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, from January 2020 to December 2025, with complete clinical data.

Exclusion criteria

Exclusion criteria: (1) Previous neck, chest, or abdominal lymph node dissection; (2) Combined with other systemic tumors or severe diseases; (3) Accompanied by lymphatic system diseases; (4) Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Overall survival, OS ;—

Secondary

MeasureTime frame
Progression Free Survival, PFS;—

Countries

China

Contacts

Public ContactPan Liang

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

229955@zju.edu.cn+86 571 8600 6156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026